Trans Tasman Radiation Oncology Group: Development of the Assessment of New Radiation Oncology Technology and Treatments (ANROTAT) Framework

Abstract

Introduction: The study aim was to develop a generic framework to derive the parameters to populate health-economic models for the rapid evaluation of new techniques and technologies in radiation oncology. Methods: A draft framework was developed through horizon scanning for relevant technologies, literature review to identify framework models, and a workshop program with radiation oncology professionals, biostatisticians, health economists and consumers to establish the Framework's structure. It was tested using four clinical protocols, comparing intensity modulated with 3D conformal therapy (post-prostatectomy, anal canal and nasopharynx) and image-guided radiation therapy techniques with off-line review of portal imaging (in the intact prostate). Results: The draft generic research framework consisted of five sequential stages, each with a number of components, and was assessed as to its suitability for deriving the evidence needed to populate the decision-analytic models required for the health-economic evaluations. A final Framework was established from this experience for use by future researchers to provide evidence of clinical efficacy and cost-utility for other novel techniques. The four clinical treatment sites tested during the project were considered suitable to use in future evaluations. Conclusions: Development of a generic research framework to predict early and long-term clinical outcomes, combined with health-economic data, produced a generally applicable method for the rapid evaluation of new techniques and technologies in radiation oncology. Its application to further health technology assessments in the radiation oncology sector will allow further refinement and support its generalisability.

A Methodology for Implementing Deep Inspiration Breath Hold Radiotherapy for Patients with Left-sided Breast Cancer in a Radiation Oncology Department Using a Clinical Study

“…Large randomized control trials comparing new and old technologies which measures endpoints such as toxicity, local control and overall survival are often impractical [17]. Recruitment could be difficult due to patients' or clinicians' bias for newer technology.…”

The Development of Stereotactic Body Radiotherapy in the Past Decade: A Global Perspective

“…Additionally, the governing body for medical reimbursement has been traditionally reluctant to reimburse advancements in technology. Although SBRT is efficient from a patient throughput perspective, it may be financially disadvantageous for the treatment facility [120]. Consequently, the initial SBRT programs in Australia were limited to public metropolitan centers where often resource allocation restrictions applied.…”

Dose planning objectives in anal canal cancer IMRT: the TROG ANROTAT experience

“…This project was undertaken by the Trans Tasman Radiation Oncology Group (TROG) in response to a commission by the Australian Government Department of Health and Ageing to develop and pilot an evaluation framework of new technologies with a view to providing improved funding for IMRT if evidence compiled by the project was compelling. 13 The purpose, objectives and specific details of the project are described in the ANROTAT protocol. 12,13 Data collection occurred between June 2011 and April 2012.…”

“…13 The purpose, objectives and specific details of the project are described in the ANROTAT protocol. 12,13 Data collection occurred between June 2011 and April 2012. The ACC section of the ANROTAT project consisted of five component studies including credentialing, dosimetry and prospective toxicity and quality of life assessment.…”